Structural basis of specific interactions of Lp-PLA2 with HDL revealed by hydrogen deuterium exchange mass spectrometry

Journal of Lipid Research

Volumn 54, Issue 1, 2013, Pages 127-133

  Cao, Jian ^a   Hsu, Yuan Hao ^a,c   Li, Sheng ^b   Woods, Virgil L ^a   Dennis, Edward A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

Apolipoproteins; Enzymology; High density lipoprotein; Lipoprotein associated phospholipase a2

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; HIGH DENSITY LIPOPROTEIN;

ARTICLE; BINDING SITE; DEUTERIUM HYDROGEN EXCHANGE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; STRUCTURE ANALYSIS;

EID: 84871197457     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M030221     Document Type: Article

References (40)

1. Dennis, E. A., J. Cao, Y. H. Hsu, V. Magrioti, and G. Kokotos. 2011. Phospholipase a(2) enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem. Rev. 111: 6130-6185.
2. Stafforini, D. M., T. M. McIntyre, M. E. Carter, and S. M. Prescott. 1987. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. J. Biol. Chem. 262: 4215-4222. (Pubitemid 17102639)
3. Tjoelker, L. W., C. Eberhardt, J. Unger, H. L. Trong, G. A. Zimmerman, T. M. McIntyre, D. M. Stafforini, S. M. Prescott, and P. W. Gray. 1995. Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad. J. Biol. Chem. 270: 25481-25487.
4. Stremler, K. E., D. M. Stafforini, S. M. Prescott, and T. M. McIntyre. 1991. Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates. J. Biol. Chem. 266: 11095-11103. (Pubitemid 21906916)
5. Stafforini, D. M., J. R. Sheller, T. S. Blackwell, A. Sapirstein, F. E. Yull, T. M. McIntyre, J. V. Bonventre, S. M. Prescott, and L. J. Roberts 2nd. 2006. Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J. Biol. Chem. 281: 4616-4623. (Pubitemid 43847720)
6. Davis, B., G. Koster, L. J. Douet, M. Scigelova, G. Woffendin, J. M. Ward, A. Smith, J. Humphries, K. G. Burnand, C. H. Macphee, et al. 2008. Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein. J. Biol. Chem. 283: 6428-6437.
7. Stafforini, D. M., M. R. Elstad, T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott. 1990. Human macrophages secret platelet-activating factor acetylhydrolase. J. Biol. Chem. 265: 9682-9687.
8. Elstad, M. R., D. M. Stafforini, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. 1989. Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor. J. Biol. Chem. 264: 8467-8470. (Pubitemid 19151553)
9. Noto, H., M. Hara, K. Karasawa, O. N. Iso, H. Satoh, M. Togo, Y. Hashimoto, Y. Yamada, T. Kosaka, M. Kawamura, et al. 2003. Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress. Arterioscler. Thromb. Vasc. Biol. 23: 829-835. (Pubitemid 36566173)
10. Thompson, A., P. Gao, L. Orfei, S. Watson, E. Di Angelantonio, S. Kaptoge, C. Ballantyne, C. P. Cannon, M. Criqui, M. Cushman, et al. 2010. Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet. 375: 1536-1544.
11. Casas, J. P., E. Ninio, A. Panayiotou, J. Palmen, J. A. Cooper, S. L. Ricketts, R. Sofat, A. N. Nicolaides, J. P. Corsetti, F. G. Fowkes, et al. 2010. PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European ancestry. Circulation. 121: 2284-2293.
12. Wilensky, R. L., and C. H. Macphee. 2009. Lipoprotein-associated phospholipase A(2) and atherosclerosis. Curr. Opin. Lipidol. 20: 415-420.
13. Packard, C. J. 2009. Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic target. Curr. Opin. Cardiol. 24: 358-363.
14. Saenger, A. K., and R. H. Christenson. 2010. Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. Clin. Chem. 56: 21-33.
15. Wilensky, R. L., Y. Shi, E. R. Mohler 3rd, D. Hamamdzic, M. E. Burgert, J. Li, A. Postle, R. S. Fenning, J. G. Bollinger, B. E. Hoffman, et al. 2008. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat. Med. 14: 1059-1066.
16. Mitsios, J. V., M. P. Vini, D. Stengel, E. Ninio, and A. D. Tselepis. 2006. Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles. Arterioscler. Thromb. Vasc. Biol. 26: 1907-1913. (Pubitemid 44305349)
17. Stafforini, D. M., M. E. Carter, G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. 1989. Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma. Proc. Natl. Acad. Sci. USA. 86: 2393-2397. (Pubitemid 19102515)
18. Tselepis, A. D., C. Dentan, S. A. Karabina, M. J. Chapman, and E. Ninio. 1995. PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme. Arterioscler. Thromb. Vasc. Biol. 15: 1764-1773.
19. Theilmeier, G., B. De Geest, P. P. Van Veldhoven, D. Stengel, C. Michiels, M. Lox, M. Landeloos, M. J. Chapman, E. Ninio, D. Collen, B. Himpens, and P. Holvoet. 2000. HDL-associated PAF-AH reduces endothelial adhesiveness in apoE-/- mice. FASEB J. 14: 2032-2039.
20. Okamura, K., S. Miura, B. Zhang, Y. Uehara, K. Matsuo, K. Kumagai, and K. Saku. 2007. Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation. Circ. J. 71: 214-219.
21. Tsimihodimos, V., S. A. Karabina, A. P. Tambaki, E. Bairaktari, G. Miltiadous, J. A. Goudevenos, M. A. Cariolou, M. J. Chapman, A. D. Tselepis, and M. Elisaf. 2002. Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia. J. Lipid Res. 43: 256-263. (Pubitemid 34184012)
22. Stafforini, D. M., L. W. Tjoelker, S. P. McCormick, D. Vaitkus, T. M. McIntyre, P. W. Gray, S. G. Young, and S. M. Prescott. 1999. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein. J. Biol. Chem. 274: 7018-7024.
23. Gardner, A. A., E. C. Reichert, M. K. Topham, and D. M. Stafforini. 2008. Identification of a domain that mediates association of platelet-activating factor acetylhydrolase with high density lipoprotein. J. Biol. Chem. 283: 17099-17106.
24. Kontush, A. C., and M. John. 2011. High-density lipoproteins: structure, metabolism, function and therapeutics John Wiley & Sons, Inc., Hoboken, New Jersey.
25. Cao, J., Y. H. Hsu, S. Li, V. L. Woods, and E. A. Dennis. 2011. Lipoprotein-associated phospholipase A(2) interacts with phospholipid vesicles via a surface-disposed hydrophobic alpha-helix. Biochemistry. 50: 5314-5321.
26. Woods, V. L., Jr., and Y. Hamuro. 2001. High resolution, high-throughput amide deuterium exchange-mass spectrometry (DXMS) determination of protein binding site structure and dynamics: utility in pharmaceutical design. J. Cell Biochem. Suppl. Suppl 37: 89-98.
27. Konermann, L., X. Tong, and Y. Pan. 2008. Protein structure and dynamics studied by mass spectrometry: H/D exchange, hydroxyl radical labeling, and related approaches. J. Mass Spectrom. 43: 1021-1036.
28. Engen, J. R. 2009. Analysis of protein conformation and dynamics by hydrogen/deuterium exchange MS. Anal. Chem. 81: 7870-7875.
29. Hebling, C. M., C. R. Morgan, D. W. Stafford, J. W. Jorgenson, K. D. Rand, and J. R. Engen. 2010. Conformational analysis of membrane proteins in phospholipid bilayer nanodiscs by hydrogen exchange mass spectrometry. Anal. Chem. 82: 5415-5419.
30. Stafforini, D. M., T. M. McIntyre, and S. M. Prescott. 1990. Platelet-activating factor acetylhydrolase from human plasma. Methods Enzymol. 187: 344-357. (Pubitemid 20309300)
31. Burke, J. E., Y. H. Hsu, R. A. Deems, S. Li, V. L. Woods, Jr., and E. A. Dennis. 2008. A phospholipid substrate molecule residing in the membrane surface mediates opening of the lid region in group IVA cytosolic phospholipase A2. J. Biol. Chem. 283: 31227-31236.
32. Burke, J. E., M. J. Karbarz, R. A. Deems, S. Li, V. L. Woods, Jr., and E. A. Dennis. 2008. Interaction of group IA phospholipase A2 with metal ions and phospholipid vesicles probed with deuterium exchange mass spectrometry. Biochemistry. 47: 6451-6459. (Pubitemid 351874236)
33. Hsu, Y. H., J. E. Burke, D. L. Stephens, R. A. Deems, S. Li, K. M. Asmus, V. L. Woods, Jr., and E. A. Dennis. 2008. Calcium binding rigidifies the C2 domain and the intradomain interaction of GIVA phospholipase A2 as revealed by hydrogen/deuterium exchange mass spectrometry. J. Biol. Chem. 283: 9820-9827.
34. Burke, J. E., A. Babakhani, A. A. Gorfe, G. Kokotos, S. Li, V. L. Woods, Jr., J. A. McCammon, and E. A. Dennis. 2009. Location of inhibitors bound to group IVA phospholipase A2 determined by molecular dynamics and deuterium exchange mass spectrometry. J. Am. Chem. Soc. 131: 8083-8091.
35. Hsu, Y. H., J. E. Burke, S. Li, V. L. Woods, Jr., and E. A. Dennis. 2009. Localizing the membrane binding region of Group VIA Ca2+-independent phospholipase A2 using peptide amide hydrogen/deuterium exchange mass spectrometry. J. Biol. Chem. 284: 23652-23661.
36. De Geest, B., D. Stengel, M. Landeloos, M. Lox, L. Le Gat, D. Collen, P. Holvoet, and E. Ninio. 2000. Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis. Arterioscler. Thromb. Vasc. Biol. 20: E68-E75.
37. Srinivasan, P. a. B., B. 2010. Molecular model of plasma PAF acetylhydrolase- lipoprotein association: insights from the structure. Pharmaceuticals. 3: 541-557.
38. Borhani, D. W., D. P. Rogers, J. A. Engler, and C. G. Brouillette. 1997. Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc. Natl. Acad. Sci. USA. 94: 12291-12296. (Pubitemid 27492521)
39. Davidson, W. S., and T. B. Thompson. 2007. The structure of apolipoprotein A-I in high density lipoproteins. J. Biol. Chem. 282: 22249-22253. (Pubitemid 47267302)
40. Tellis, C. C., and A. D. Tselepis. 2009. The role of lipoprotein- associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma. Biochim. Biophys. Acta. 1791: 327-338.